GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (LTS:0RK9) » Definitions » Policy Acquisition Expense

Alligator Bioscience AB (LTS:0RK9) Policy Acquisition Expense


View and export this data going back to 2016. Start your Free Trial

What is Alligator Bioscience AB Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Alligator Bioscience AB Business Description

Traded in Other Exchanges
Address
Medicon Village, Scheeletorget 1, Lund, SWE, 223 81
Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. Its drug candidate mitazalimab, is currently in preparation for Phase 3 development, and has previously presented unprecedented survival data at 18-months follow up in first-line metastatic pancreatic cancer patients in the Phase 2 trial OPTIMIZE-1.